Levomepromazine vs atypical antipsychotics
Leaving the study early ‐ short term ‐ lost to · patients with schizophrenia
Levomepromazine showed no clear difference in leaving the study early ‐ short term ‐ lost to compared with atypical antipsychotics (low certainty).
1 finding from 1 review
- RR 0.33 [0.01, 7.74]1 study · 42 participantsLow